ITCI
Intra-Cellular Therapies, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website intracellulartherapies.com
- Employees(FY) 561
- ISIN US46116X1019
Performance
+14.41%
1W
+18.27%
1M
+9.93%
3M
+20.51%
6M
+20.83%
YTD
+70.12%
1Y
Profile
Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, heart failure, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.
Technical Analysis of ITCI 2024-11-01
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-02 09:33
- 2024-11-01 08:26
- 2024-10-31 03:07
- 2024-10-30 11:02
- 2024-10-30 08:40
- 2024-10-30 08:07
- 2024-10-30 07:40
Intra-Cellular: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-10-30 07:30
- 2024-10-29 19:30
- 2024-10-28 21:05
- 2024-10-23 10:01
- 2024-10-17 08:00
- 2024-10-16 20:00
- 2024-10-13 19:23
- 2024-10-13 07:23
- 2024-10-11 10:30
- 2024-10-11 07:10
- 2024-10-10 15:05
- 2024-10-04 06:44
- 2024-09-23 08:00
- 2024-09-22 20:00
- 2024-09-13 11:06
- 2024-09-06 11:31
- 2024-09-06 08:23
- 2024-09-05 01:12
- 2024-09-03 03:49
- 2024-09-02 06:05
10 Best Mid-Cap Healthcare Stocks To Buy Now(Insidermonkey)
- 2024-08-28 08:00
- 2024-08-27 20:00
- 2024-08-26 03:13
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.